Undiagnosed diseases: Needs and opportunities in 20 countries participating in the Undiagnosed Diseases Network International

Author:

Taruscio Domenica,Salvatore Marco,Lumaka Aimè,Carta Claudio,Cellai Laura L.,Ferrari Gianluca,Sciascia Savino,Groft Stephen,Alanay Yasemin,Azam Maleeha,Baynam Gareth,Cederroth Helene,Cutiongco-de la Paz Eva Maria,Dissanayake Vajira Harshadeva Weerabaddana,Giugliani Roberto,Gonzaga-Jauregui Claudia,Hettiarachchi Dineshani,Kvlividze Oleg,Landoure Guida,Makay Prince,Melegh Béla,Ozbek Ugur,Puri Ratna Dua,Romero Vanessa,Scaria Vinod,Jamuar Saumya S.,Shotelersuk Vorasuk,Roccatello Dario,Gahl William A.,Wiafe Samuel A.,Bodamer Olaf,Posada Manuel

Abstract

IntroductionRare diseases (RD) are a health priority worldwide, overall affecting hundreds of millions of people globally. Early and accurate diagnosis is essential to support clinical care but remains challenging in many countries, especially the low- and medium-income ones. Hence, undiagnosed RD (URD) account for a significant portion of the overall RD burden.MethodsIn October 2020, the Developing Nations Working Group of the Undiagnosed Diseases Network International (DNWG-UDNI) launched a survey among its members, belonging to 20 countries across all continents, to map unmet needs and opportunities for patients with URD. The survey was based on questions with open answers and included eight different domains. Conflicting interpretations were resolved in contact with the partners involved.ResultsAll members responded to the survey. The results indicated that the scientific and medical centers make substantial efforts to respond to the unmet needs of patients. In most countries, there is a high awareness of RD issues. Scarcity of resources was highlighted as a major problem, leading to reduced availability of diagnostic expertise and research. Serious equity in accessibility to services were highlighted both within and between participating countries. Regulatory problems, including securing informed consent, difficulties in sending DNA to foreign laboratories, protection of intellectual property, and conflicts of interest on the part of service providers, remain issues of concern. Finally, most respondents stressed the need to strengthen international cooperation in terms of data sharing, clinical research, and diagnostic expertise for URD patients in low and medium income countries.DiscussionThe survey highlighted that many countries experienced a discrepancy between the growing expertise and scientific value, the level of awareness and commitment on the part of relevant parties, and funding bodies. Country-tailored public health actions, including general syllabus of medical schools and of the education of other health professionals, are needed to reduce such gaps.

Publisher

Frontiers Media SA

Subject

Public Health, Environmental and Occupational Health

Reference35 articles.

1. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database;Nguengang Wakap;Eur J Hum Genet.,2020

2. An act to amend the Public Health Service Act to establish an Office of Rare Diseases at the National Institutes of Health, and for other purposes

3. 35 years of Japanese policy on rare diseases;Hayashi;The Lancet,2008

4. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support;Anderson;Orphanet J Rare Dis.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3